Skip to main content

Research

COVID antiviral speeds recovery but doesn't reduce hospitalisation in vaccinated patients

23 April 2026

Major UK and Canadian studies provide crucial evidence for who should receive Paxlovid in today's highly vaccinated populations

Tracing magma’s hidden journey: researchers show fault systems guide and halt volcanic unrest

23 April 2026

Cardiff researcher part of international team that investigated 2022 volcanic system crisis in Azores

Bowelbabe Fund for Cancer Research UK supports Cardiff researchers to explore the development of a universal bowel cancer vaccine

7 April 2026

As the Bowelbabe fund reaches more than £20m, two new major research investments – including one at Cardiff University - are announced.

Land value capture in the planning system is a distraction from the redistributive measures needed to tackle England’s housing crisis

7 April 2026

Academics say more decisive action is required to deal with housing inequalities

TIME recognition for academic excellence

27 March 2026

Cardiff University is 121st in TIME magazine’s inaugural World’s Top Universities 2026

Removing barriers to participation for people who cannot consent to studies

27 March 2026

The ACCORD programme will examine the barriers that prevent adults who lack capacity to consent from taking part in clinical research.

Nurse-led programme helps prevents violence and improves emergency care

27 March 2026

Researchers recommend UK-wide roll out of Violence Prevention Teams in hospitals as a ‘transformative model’ to help tackle inequalities and to significantly improve patient outcomes

New PTSD therapy for military veterans

26 March 2026

A new tailored PTSD therapy is an effective and scalable treatment option for veterans.

Cardiff ranks among world’s best universities in major global rankings

25 March 2026

Eight subjects in Top 100 of 2026 QS World University Rankings by Subject

International team identifies immune pathway that may explain how probiotics influence cancer treatment outcomes

24 March 2026

Cardiff and Kumamoto researchers uncover how a common probiotic, when given alongside immunotherapy, can activate tumour-killing immune cells.